Intestinal Dialysis™
A Break Through Technology
In transition from Kidney health supplement to a live biotherapeutic product (LBP) development under CBER/USFD approved Investigational New Drug(IND) for multisite RCT, CKD patients (N=630).For more details refer to Clinical Trials.
Intestinal Dialysis™ (a.k.a Enteric Dialysis®) – Modulating the Gut Microbiome with Probiotics and Prebiotics (Gut-Kidney Connection)
Kibow's - Intestinal Dialysis™
Award winning and patented technology
2020 Business of the Year
Delaware County Chamber of Commerce
Bio - Biotechnology Innovation Organization
2005 - Innovation Corridor Abstract Winner, Boston, MA
2018 - Invited Company for Presentation, Boston, MA
2014 - A “Buzz of Bio" Winner
Pipelines of Promise category, International Bio conference, San Diego, CA
The first dietary supplement Company nominated to participate in the "Buzz of Bio".
2019 - Dun & Bradstreet Award
In recognition of unwavering commitment to business growth
Subscribe Newsletter &
Get Company News
Kibow Pharmaceuticals, LLC is a newly created corporation established in Oct 01 2019. Wholly owned subsidiary of Kibow Biotech Inc.
Company’s vision and mission is to develop Live Biotherapeutic drug for all stages of Chronic Kidney Disease (CKD).
Kibow Pharmaceuticals, LLC
4781 West Chester Pike
Newtown Square, PA 19073
Email: info@kibowpharma.com
Phone: 610-353-5130 || Fax: 610-353-5110